During the past decade, Palo Alto Medical Foundation Health Care conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 69 clinical trials were completed, i.e. on average, 71.1% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 50 clinical trials were completed. i.e. 185.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palo Alto Medical Foundation Health Care" #1 sponsor was "National Cancer Institute (NCI)" with 78 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "NRG Oncology" with 7 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation Health Care" #1 collaborator was "National Cancer Institute (NCI)" with 66 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation Health Care" are "Invasive Breast Carcinoma" (8 trials), "Recurrent Breast Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Recurrent Fallopian Tube Carcinoma" (7 trials) and "Recurrent Primary Peritoneal Carcinoma" (7 trials). Many other conditions were trialed in "Palo Alto Medical Foundation Health Care" in a lesser frequency.

Most popular intervention types in "Palo Alto Medical Foundation Health Care" are "Drug" (122 trials), "Other" (96 trials), "Biological" (63 trials), "Procedure" (36 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (43 trials), "Computed Tomography" (21 trials), "Paclitaxel" (20 trials) and "Cisplatin" (18 trials). Other intervention names were less common.

The vast majority of trials in "Palo Alto Medical Foundation Health Care" are 113 trials for "All" genders, 34 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Palo Alto Medical Foundation Health Care". undefined are not yet recruiting, 32 are recruiting, 82 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Palo Alto Medical Foundation Health Care, 3 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Palo Alto Medical Foundation Health Care, 4 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".